VanEck Pharmaceutical ETF
PPH
PPH
46 hedge funds and large institutions have $60.8M invested in VanEck Pharmaceutical ETF in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
29% less capital invested
Capital invested by funds: $85.5M → $60.8M (-$24.7M)
Holders
46
Holding in Top 10
–
Calls
$1.37M
Puts
$473K
Top Buyers
| 1 | +$6.07M | |
| 2 | +$1.54M | |
| 3 | +$385K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$350K |
| 5 |
CFGS
Concourse Financial Group Securities
Birmingham,
Alabama
|
+$124K |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$15.2M | |
| 3 | -$3.48M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.14M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$91K |